Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Ready to take the right step
Suicidal Ideation Concerns and Regulatory Review The FDA has reviewed reports of suicidal thoughts with GLP-1 receptor agonists
One orthopedic specialist wrote that regulatory agencies must crack down on practitioners and pharmacies that expose patients to unapproved peptides
Table of contents Zealand Pharma Headquarters: Denmark Technology: GLP-1 receptor agonist Lead candidate: Survodutide Danish biotech company Zealand Pharma is developing peptide therapies to treat metabolic diseases like type 1 diabetes and obesity, as well as rare diseases and inflammatory conditions
US$ 26.00
US$ 28.67
US$ 23.66
US$ 21.23
